This paper is in the following e-collection/theme issue:

Public Health (231) Theme Issue: The New Digital Normal in Health and Medicine (40) JMIR Theme Issue: COVID-19 Special Issue (2512) Outbreak and Pandemic Preparedness and Management (1793) Infectious Diseases (non-STD/STI) (1674) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1537) Depression and Mood Disorders; Suicide Prevention (1562) Electronic Health Records (1218)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39455, first published .
Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data

Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data

Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data

Authors of this article:

Md Mahmudur Rahman1 Author Orcid Image ;   Atqiya Munawara Mahi1 Author Orcid Image ;   Rachel Melamed2 Author Orcid Image ;   Mohammad Arif Ul Alam1, 3 Author Orcid Image
Article Authors Cited by (2) Tweetations (6) Metrics

Journals

  1. Tsiakalos A, Ziakas P, Polyzou E, Schinas G, Akinosoglou K. Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis. Microorganisms 2023;11(8):2073 View
  2. Gao Z, Dorney I, Davis P, Kaelber D, Xu R. Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease. Journal of Alzheimer’s Disease 2024;102(1):99 View